vimarsana.com

Page 2 - வாழ்க்கை அறிவியல் லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Glenmark Life Sciences Q1 profit rises to Rs 100 9 cr; revenue up 32 2%

Novel Drugs are Being Investigated for Gaucher s Disease

Novel Drugs are Being Investigated for Gaucher s Disease
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Anatara Lifesciences Limited | Company Summary | ASX:ANR ISIN:AU000000ANR0 | Australian Stock Exchange ABN Newswire

Anatara is pleased that activities for the March quarter progressed favourably and near to anticipated timelines. There appears to be a wider appreciation of Anatara s human health initiatives with a focus on using the restoration and/or maintenance of gastrointestinal tract harmony to improve overall wellbeing.Read Full Article▸ On 14 December 2020, Anatara Lifesciences Limited (ASX:ANR) announced details of an off-market share buy-back facility (Buy-Back Facility) to buyback all of the shares held by shareholders who held unmarketable parcels of shares in the Company.Read Full Article▸ Anatara Lifesciences (ASX:ANR) is pleased to advise that it is has received Human Research Ethics Committee (HREC) approval to undertake a clinical trial of its Gastrointestinal Re-Programming complementary medicine (GaRP) in participants with irritable bowel syndrome - diarrhoea subtype (IBS-D).Read Full Article▸

RPG Life Sciences Ltd Q1FY22 PAT surges to Rs 13 58 crores

RPG Life Sciences Ltd Q1FY22 PAT surges to Rs 13 58 crores
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.